Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Eur J Sport Sci. 2016 Sep 20;17(3):317–325. doi: 10.1080/17461391.2016.1230892

Table 2.

Average heart rate and blood pressure for pomegranate extract (PE) and placebo (PL) during repeated sprint ability (RSA) test and repetitions to fatigue (RTF) test (Mean ± SD).

Heart Rate (bpm) Blood Pressure (mmHg)

PE PL PE PL
RSA
Baseline 71.8 ± 10.4 73.1 ± 12.4 116/73 ± 11.5 116/76 ± 12.6
30minPI 69.3 ± 12.6* 68.4 ± 9.0* 117/75 ± 11.4 119/74 ± 7.8
IPost 152.2 ± 14.1* 151.5 ± 17.8* 138/73 ± 16.8* 134/74 ± 20.5*
30minPost 90.0 ± 11.6* 91.6 ± 14.7* 110/72 ± 9.1* 108/71 ± 7.6*
RTF
Baseline 70.9 ± 13.4 68.8 ± 11.0 118/74 ± 10.7 117/73 ± 11.7
30minPI 66.8 ± 13.2 64.9 ± 8.9 117/70 ± 12.2 116/74 ± 11.1
IPostBench 134.5 ± 21.9* 138.6 ± 18.4* 125/67 ± 12.4* 125/67 ± 12.3*
IPostLeg 149.5 ± 17.0* 150.7 ± 16.3* 131/71 ± 13.6* 135/71 ± 16.7*
30minPost 73.7 ± 11.4 74.2 ± 9.3 109/71 ± 17.6 114/68 ± 10.8
*

denotes significant main effect for time (P <0.05). There was no treatment effect for heart rate or blood pressure.